Akiko Nishiyama Explains the Many Strengths of a Degree in Physiology and Neurobiology – UConn Today – UConn Today
By daniellenierenberg
Forty years ago,neurologistsand neurobiologistsbelieved that the adult brain became lessplastic and less able to learn and retain new things.Theyhad no idea that non-neuronal cells had anything to do with information processing in the brain, including learning and memory.
Now,afterdecades of researchingand characterizinga particular cell type, called glial cells, in the brain, Akiko Nishiyama, professor of physiology and neurobiology and the new department head,can tell youthatthese cells areessential to enabling humans to learn new tasks well into adulthood, thanks to a very dynamic regulation of the ability of oligodendrocyte precursor cells she had found to generate mature myelin-forming cells. She believes that these cells also play a yet unidentified critical role in the network of brain activity.
We sat down with Nishiyama to talk about her goals for the department and current trends in the growing field of physiology and neurobiology.
What isthephysiology and neurobiology (PNB)majorat UConn?
Physiology is the study of how different parts of the body work, andneurobiology is the study of how the nervous system (brain, spinal cord, and peripheral nerves) works, and this is what I study.ThePNBdepartmentis where faculty andstudentsstudy both disciplines.
In the early- to mid-20th Century, we saw a tremendous expansion of the study of the nervous system, which led to the emergence of a multi-disciplinary field called neurobiology. The name of our department reflects this transition.
How did you get started inneurobiology? Tell us about your research.
I startedmy career in neuropathologyafter finishing six years of medical training.I was curious about how different cells in the nervous system support the function of neurons and how these support cells, known as glial cells, might malfunction in the process of neurodegenerative diseases. Halfway through the residency-doctoral program, I switched to a more basic doctoral program in molecular neurobiology, because I wanted to ask fundamental molecular and cellular questions about how different glial cells in the nervous system interact with neurons.
I sought my postdoctoral training in a lab studying the NG2 protein that seemed to be present in a yet-unidentified subset of glia,andI spent my career characterizing them.
Thirty years later, these cells have become widely known to cellular neurobiologists and have made it into textbooks. My studies established that NG2 cells are precursor cells to oligodendrocytes that make myelin sheaths but are different from stem cells or other known glial cell types.
Now we know these myelin structures are constantly being remodeled as we learn new skills as adults. And if you disrupt the process of the precursor cells, you disrupt the ability to acquire new tasks or learn new motor skills.
Why are these cells important?
We used to think that myelin was formed during the few years after birth and remained stable throughout life.What I found was that oligodendrocyte precursor cells persist in the adult brain and are implicated in some neurological disorders, such as multiple sclerosis.
Thisis an expanding areaof research in a new field called myelin plasticity.Myelin repair is important for the functional repair not only in multiple sclerosis but also after trauma such as spinal cord injury. New genomic studies are emerging that have linked oligodendrocytes to neuropsychiatric and neurodegenerative diseases such as schizophrenia and Parkinsons disease.
What are some of the things you can do with a degree in PNB?
We provide a wide-ranging set of skills, collectively, in the department, because the possibilities grow every day.
Many of our undergraduate students pursue medical, dental, or other health care professions. For instance, we recently developed theInteroperative Neuromonitoring Programwith a masters degree in Surgical Neurophysiology. This program trains specialized medical technologists who monitor the patients muscle and brain activity and other neurophysiologicalindicatorsduring surgery that may be important for surgeons and anesthesiologists to see in real-time.
Some PNB majors go to graduate school to pursue a career in academic or industry research. In addition,students withan advanced degree inphysiology andneurobiology can become teachers or science writers.
Regardless of whether they are pursuing research, we train our undergraduate students to develop a good habit ofidentifying and thinkingthrough a problem. We have faculty with diverse expertise, and our students are introduced to a wide range of questions and approaches to answer them in the classroom as well as in faculty laboratories.
What are some of your goals for the department over the next five years?
Imreally luckyto have astrong andfriendly department. Its a smallenoughdepartment that I can get to knoweach faculty and staff memberquite well.
I would like tobetter connectwith our undergraduate majors early during their time at UConn. Currently, we see them for the first time when they take our gatewayHuman Physiology and Anatomycourse in their sophomore year, and most of our faculty do not see them until they are juniors or seniors. I am interested in exposing freshmen and early sophomores to more experientialtypesof learning, monitoring their progress, and providing feedback and support where needed.
One of the strengths of our department is our facultys research. Many of our faculty, especially the younger faculty, have expanding research programs, have been successful in securing large external grants, and are active in mentoring graduate and undergraduate students in their labs. I would like to provide an environment where the successful faculty can attain an even greater level of excellence and as a department attract a larger number of talented doctoral and postdoctoral trainees to UConn.
I would like to strengthen our graduate program to providemoremultidisciplinary training for the next generation of physiologists andneurobiologiststo gain quantitative and computer skillsas well.
Go here to read the rest:
Akiko Nishiyama Explains the Many Strengths of a Degree in Physiology and Neurobiology - UConn Today - UConn Today
- Bone marrow mesenchymal stem cells modulate miR-202-3p to suppress neuronal apoptosis following spinal cord injury through autophagy activation via... - December 9th, 2024
- Stem Cells Reveal Secret to Beneficial Proteins for mRNA Therapy - An Interview with Neuroscientist Prof. Dr. Antal Ngrdi - Szegedi Tudomnyegyetem - December 9th, 2024
- Much-anticipated human trial aiming to repair spinal cord damage about to begin - ABC News - October 21st, 2024
- The Science Of Health: Are Spinal Cord Injuries Irreversible? Know Science Advances That Can Cure Them In The Future - ABP Live - October 16th, 2023
- Evaluating the Growth Prospects of the Global Nerve Repair & Regeneration Market at a CAGR of 6.5% | Emergen - EIN News - April 21st, 2023
- Regenerative Therapies Market is Set to Grow at a CAGR of 8.7% by 2033, Propelled by Advancements in - EIN News - March 17th, 2023
- Kadimastem Submits IND Application to the FDA for its Phase IIa Clinical Trial with AstroRx for the Treatment of ALS - Marketscreener.com - February 21st, 2023
- My Back Is All F*cked Up 55-Year-Old Joe Rogan Curses at Worst Jiu-Jitsu for Painful Health Condition - EssentiallySports - February 21st, 2023
- Brain and Spinal Cord Tumors: Hope Through Research - January 3rd, 2023
- 14.3 The Brain and Spinal Cord Anatomy & Physiology - January 3rd, 2023
- Stem Cell Therapy for Spinal Cord Injury - PubMed - January 3rd, 2023
- Spinal cord injury - Diagnosis and treatment - Mayo Clinic - December 25th, 2022
- Spinal Cord Injury: Hope Through Research | National Institute of ... - December 1st, 2022
- Stem cell controversy - Wikipedia - October 13th, 2022
- Stem Cells Australia | Australian research, stem cell treatments and ... - October 13th, 2022
- The eye and stem cells: the path to treating blindness - October 13th, 2022
- World's first stem cell treatment for spina bifida delivered during fetal surgery - UC Davis Health - October 13th, 2022
- Fighting One Disease or Condition per Day - Daily Kos - October 13th, 2022
- UPDATE: NurExone Signs Letter of Intent with Nanometrix for Its Exosome and Cargo Molecular Profiling AI-Driven Technology - Yahoo Finance - October 13th, 2022
- Global Cell Therapy Market Report (2022 to 2028) - Featuring Thermo Fisher Scientific, MaxCyte, Danaher and Avantor Among Others -... - October 13th, 2022
- Horizon Therapeutics plc Announces New UPLIZNA (inebilizumab-cdon) Data in Neuromyelitis Optica Spectrum Disorder (NMOSD) to be presented at ECTRIMS... - October 13th, 2022
- Physiology, Spinal Cord - StatPearls - NCBI Bookshelf - October 5th, 2022
- IMAC Holdings, Inc. Announces Completion of Third Cohort of its Phase 1 ... - October 5th, 2022
- Revolutionary Jab that Could Repair Spinal Cord Injuries Developed by Scientists - Good News Network - October 5th, 2022
- How the 'Love Hormone' Oxytocin May Help Heal Heart Muscles - Healthline - October 5th, 2022
- Unlocking the Mysteries of Brain Regeneration Groundbreaking Study Offers New Insight - SciTechDaily - October 5th, 2022
- In Conversation: How to understand chronic pain - Medical News Today - October 5th, 2022
- New drug could cure aggressive brain cancer stopping tumours in their tracks... - The US Sun - September 27th, 2022
- Rehabilitating spinal cord injury and stroke with graphene and gaming - Nanowerk - September 19th, 2022
- Induced Pluripotent Stem Cells Market Reaches at a CAGR of 8.0% in the Forecast Periods [2021-2031] - BioSpace - September 19th, 2022
- Axolotls can regenerate their brains - Big Think - September 19th, 2022
- IMAC Holdings, Inc. Announces Completion of Third Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the... - September 11th, 2022
- Spinal Muscular Atrophy: Causes and importance of early diagnosis for proactive management - Firstpost - September 11th, 2022
- Increasing Road Accidents and Fall Injuries among Aged Population Primarily Driving Need for Orthopedic Navigation Systems: Fact.MR Analysis - Yahoo... - September 3rd, 2022
- Culture of human nasal olfactory stem cells and their extracellular vesicles as advanced therapy medicinal products - Newswise - August 10th, 2022
- Curious kids: what is inside teeth? - The Conversation - August 10th, 2022
- Human placental mesenchymal stem cells derived exosomes improved functional recovery via attenuating apoptosis and increasing axonal regeneration... - August 2nd, 2022
- How the Regenerative Properties of Glioblastoma Can Be Terminated - Gilmore Health News - August 2nd, 2022
- New TSXV listing looks to address the $3B spinal cord injury treatment market (NRX.V) - FXStreet - July 25th, 2022
- Human iPSC co-culture model to investigate the interaction between microglia and motor neurons | Scientific Reports - Nature.com - July 25th, 2022
- Negligence in treatment of diseases like glioblastoma can be fatal, seminar told - The News International - July 25th, 2022
- What lab-grown cerebral organoids are revealing about the brain - New Scientist - July 25th, 2022
- Innovative Therapies, Care Equity Highlight 2022 ASCO Annual Meeting - Targeted Oncology - July 16th, 2022
- Global Stem Cell Manufacturing Market Value Projected To Reach USD 21.71 Billion By 2029, Registering A CAGR Of 9.1% - Digital Journal - July 16th, 2022
- Stem Cell Therapy Market Is Expected To Reach USD 455.61 Billion By 2027 At A CAGR Of 16 percent By Forecast 2027 Says Maximize Market Research (MMR)... - June 30th, 2022
- This startup wants you to have a personal stem cell stash - Freethink - June 30th, 2022
- Parents of 12-Year-Old Boy Praying for a Miracle, Appealing UK Judge's Decision to Remove Life Support - CBN.com - June 30th, 2022
- The end of Roe v. Wade affects more than just abortion - Vox.com - June 30th, 2022
- Horizon Therapeutics plc Submits Regulatory Filing for UPLIZNA (inebilizumab) in Brazil - Business Wire - June 20th, 2022
- Effect of Electrical Stimulation on Spinal Cord Injury: In Vitro and In Vivo Analysis - Newswise - June 11th, 2022
- First-of-its-Kind Stem Cell and Gene Therapy Highlighted at Annual Stem Cell Meeting - Newswise - June 11th, 2022
- UK Judge to Decide if 12-Year-Old Will Be Removed from Life Support, Parents Beg for More Time to Heal - CBN.com - June 11th, 2022
- 'This is my life, and I'll try anything to save it': Woman with MS raising funds for treatment - The Brandon Sun - May 29th, 2022
- Racing Thoughts: Quadriplegic Man Drives Race Car With His Brain - Newsy - May 29th, 2022
- Physical therapy for vertigo: Exercises, benefits, and more - Medical News Today - May 29th, 2022
- Researchers find new function performed by almost half of brain cells - Medical News Today - May 13th, 2022
- Texas Family Fights to Access $2.1 Million Treatment for Baby - NBC 5 Dallas-Fort Worth - May 13th, 2022
- Severe COVID-19 may cause cognitive deficits equivalent to 20 years of aging - Medical News Today - May 13th, 2022
- Stem Cell Magic: 5 Promising Treatments For Major Medical Conditions - Study Finds - April 29th, 2022
- Neural Stem Cell Therapy For Spinal Cord Injury To Tap Into The Potential Of Stem Cells - Optic Flux - April 15th, 2022
- Still Blooming: Sams mission to raise money for spinal cord injury research - 7NEWS - April 15th, 2022
- Lineage and Cancer Research UK Announce Completion of Patient Enrollment in Phase 1 Clinical Study of VAC2 for the Treatment of Non-small Cell Lung... - April 15th, 2022
- Lineage Announces Pipeline Expansion to Include Auditory Neuronal Cell Therapy for Treatment of Hearing Loss - Galveston County Daily News - March 22nd, 2022
- COVID-19: Even mild to moderate infection may cause brain anomalies - Medical News Today - March 22nd, 2022
- Scots mum with MS says 50k treatment abroad is 'last hope' of halting disease - Daily Record - January 18th, 2022
- Mending the gap: U of T's Molly Shoichet joins team developing new treatments for spinal cord injuries - News@UofT - January 18th, 2022
- Spinal Cord Injury Information Page | National Institute ... - January 3rd, 2022
- Dancing molecules successfully repair severe spinal cord ... - January 3rd, 2022
- Best 2021 Medical Breakthroughs And Treatments to Beat Cancer, Alzheimer's, Diabetes & More - Good News Network - January 3rd, 2022
- Global Regenerative Medicine Market is Expected to Reach USD 57.08 Billion by 2027, Growing at a CAGR of 11.27% Over the Forecast Period. -... - December 23rd, 2021
- Scientists unravel a gene function that helps the genesis of neurons - Research Matters - December 23rd, 2021
- The 10 Most Compelling Research Stories of 2021 PharmaLive - PharmaLive - December 23rd, 2021
- 2021: The year in review | YaleNews - Yale News - December 23rd, 2021
- Polymyositis Pipeline to Progress with New and Emerging Drugs for Treatment, Analyzes DelveInsight - GlobeNewswire - December 10th, 2021
- Cell and Gene Therapy Market to reach US$ 47,095.2 Mn by end of 2028, Says Coherent Market Insights - PRNewswire - November 22nd, 2021
- From asthma to cancer to infertility, the new treatments, jabs and meds making us healthier... - The Sun - November 22nd, 2021
- Improving motor neuron-like cell differentiation of hEnSCs by the combination of epothilone B loaded PCL microspheres in optimized 3D collagen... - November 8th, 2021
- Team finds way to enhance stem cell therapy for CNS injuries - BioPharma-Reporter.com - October 28th, 2021
- 'Rogue' antibodies found in brains of teens with delusions and paranoia after COVID-19 - Livescience.com - October 28th, 2021
- Traumatic Spinal Cord Injury: An Overview of ... - October 16th, 2021